---
category: news
title: "Relay buys AI startup to aid unorthodox drug discovery quest"
excerpt: "The $85 million acquisition is an unusual and early step for a company like Relay, which went public last July and only just began clinical testing of its lead drugs last year."
publishedDateTime: 2021-04-16T16:29:00Z
originalUrl: "https://www.biopharmadive.com/news/relay-acquire-zebiai-ai-drug-discovery/598550/"
webUrl: "https://www.biopharmadive.com/news/relay-acquire-zebiai-ai-drug-discovery/598550/"
type: article
quality: 37
heat: 37
published: false

provider:
  name: BioPharma Dive
  domain: biopharmadive.com

topics:
  - AI

images:
  - url: "https://www.biopharmadive.com/user_media/cache/c5/72/c572d5a296c20a66f212559314e53244.jpg"
    width: 770
    height: 364
    isCached: true

related:
  - title: "Relay Therapeutics pays $85M for startup with a new AI tech for drug discovery"
    excerpt: "Relay Therapeutics has its own technology that applies artificial intelligence and machine learning techniques to drug discovery. Its $85 million acquisition of ZebiAI gives it another technology that applies ML to DNA-encoded libraries and predicts the small molecules with the potential to drug proteins."
    publishedDateTime: 2021-04-16T19:03:00Z
    webUrl: "https://medcitynews.com/2021/04/relay-therapeutics-pays-85m-for-startup-with-a-new-ai-tech-for-drug-discovery/"
    type: article
    provider:
      name: MedCity News
      domain: medcitynews.com
    quality: 33
    images:
      - url: "https://medcitynews.com/uploads/2017/02/GettyImages-172595086.jpg"
        width: 683
        height: 512
        isCached: true
  - title: "Relay Therapeutics acquires AI startup for $85M"
    excerpt: "Relay Therapeutics, the Cambridge precision medicine company that raced onto the stock market last summer with one of the largest IPOs in the biotech industry, is looking to build out its data science capabilities."
    publishedDateTime: 2021-04-16T18:42:00Z
    webUrl: "https://www.bizjournals.com/boston/news/2021/04/16/relay-therapeutics-acquires-ai-startup-for-85m.html"
    type: article
    provider:
      name: The Business Journals
      domain: bizjournals.com
    quality: 17

secured: "RaUZvrxEfadwwKw/t24VE9sMPZP+T0SY5hbdXZxeXdxKZ9NPSAr4iSiubUpzct+mS8HxUJPscU644gOcuow306kn5E5oNsfbbZNhUWVxNJ91KUuGmRjv/tKunLCNU0LMYHPU8Z+LS/8KDceRSK+vKALj0ds3Bm9NO9+vRTuhySfMzPT4ba2ibGl/FCKs5CnUgLfJM1/v9H0zyY0r+3+2eZJ9U53KsbdYfZlwdAUxh8iiC/ZfuMMgf9n9QiKn4ZYfaL0ePiBGUjZVzcHV8qxjwI30dEMMh8Eca6kwKX7wEnaQbzJfuFjF0Vla8qQD8l+1cFFZ3zcAyrg/PJLPoSIJhH7ujC1Ri/TqNUSxYUkNCWg=;z97fSnqDwCNsi8pdfqILqg=="
---

